Scientists have developed a promising new method to combat the age-related losses in muscle mass that often accompany immobility after injury or illness. Their technique, demonstrated in mice, arrests the process by which muscles begin to deteriorate at the onset of exercise after a period of inactivity.
A recent study by the TU Dresden and the University of Zurich in cooperation with the Max Planck Institute for the Science of Light establishes for the first time a link between depressive disorders and mechanical characteristics of all major blood cell types. The results suggest that depressive disorders, and in particular persistent depressive disorders, are associated with a general increase in the deformability of immune cells, which could indicate deteriorated cell function and further explain the general exhaustion in many depression patients.
Yale scientists have discovered that a protein known as augmentor-alpha regulates body weight in mice, an insight that could lead to new treatments for metabolic disorders.
An experimental immunotherapy can temporarily reprogram patients’ immune cells to attack a specific target via only a single injection of messenger RNA (mRNA), similar to the mRNA-based COVID-19 vaccines, according to a new study from researchers in the Perelman School of Medicine.
Newly published research details how a team of scientists from the University Miguel Hernández (Spain), the Netherlands Institute of Neuroscience (Netherlands) and the John A. Moran Eye Center at the University of Utah (USA) successfully created a form of artificial vision for a blind woman using a brain implant.